Hormone allergy and skin reactions

Autoimmune Progesterone Dermatitis: Could Your Monthly Rash Be a Progesterone Allergy?

Autoimmune progesterone dermatitis, now often described more broadly as
progestogen hypersensitivity, is a rare condition in which naturally produced
progesterone or a progesterone-containing medicine triggers recurrent allergic or inflammatory symptoms.

What is autoimmune progesterone dermatitis?

Progesterone rises after ovulation during the luteal phase of the menstrual cycle.
In people with progestogen hypersensitivity, this natural rise may trigger skin, mucosal or systemic
symptoms. Reactions may also follow exposure to synthetic progestogens in contraception,
fertility treatment, hormone replacement or other hormonal medicines.

The older term “autoimmune progesterone dermatitis” remains widely recognised, but it can
be misleading because not every reaction is proven to be autoimmune and not every patient has dermatitis.
The term progestogen hypersensitivity better reflects the range of possible reactions,
which includes urticaria, angioedema, breathing symptoms and anaphylaxis, as well as eczema-like rashes.

What did the 2026 research find?

A 2026 clinical study reviewed 13 patients diagnosed with autoimmune progesterone
dermatitis. The average age at which symptoms began was 24 years. Every patient reported
worsening around the menstrual period, and the most common skin presentation was
urticaria. Itching was reported by all patients.

The researchers emphasised that skin testing may support the diagnosis but is
not sufficiently reliable to be used alone. A negative progesterone skin test does not
exclude the condition, and false-positive results can occur. Diagnosis therefore depends heavily on a
detailed clinical history and the reproducible relationship between symptoms, the menstrual cycle and
exposure to hormonal medicines.

Other 2026 publications have reinforced the importance of recognising the severe end of the spectrum.
A literature review identified documented cases of both endogenous and medication-triggered
progesterone-induced anaphylaxis, including reactions associated with assisted
reproduction. The authors highlighted variation in testing methods and the need for individualised
management, particularly where progesterone is required for fertility treatment.

What does a progesterone-related rash look like?

There is no single characteristic rash. Symptoms may change from one cycle to another and may resemble
more common skin conditions. Reported presentations include:

• Hives or urticaria — raised, itchy welts that may move around the body.
• Angioedema — deeper swelling, often affecting the eyelids, lips, hands or feet.
• Eczema-like dermatitis — red, dry, inflamed or intensely itchy patches.
• Erythema multiforme-like lesions — round or target-shaped areas.
• Mouth or genital symptoms — including soreness, ulcers or cyclical vulval eruptions.
• Breathing or systemic symptoms — wheeze, throat tightness, dizziness, collapse or
  anaphylaxis.

When do symptoms occur?

In endogenous progestogen hypersensitivity, symptoms typically begin after ovulation as progesterone rises.
A recurring flare in the days before menstruation, followed by improvement at or soon after the start of
the period, is highly suggestive.

However, timing is not always textbook. Symptoms can be influenced by irregular cycles, pregnancy,
the postnatal period, perimenopause, contraceptive use and fertility treatment. Some patients first develop
symptoms after exposure to a progesterone or progestin medicine, while others have never used one.

How is progestogen hypersensitivity diagnosed?

There is currently no single universally accepted gold-standard test. Assessment should be performed by a
clinician experienced in allergy, dermatology and, where appropriate, gynaecology. A careful history is
central to diagnosis.

1. A detailed symptom and menstrual-cycle history

Patients may be asked to record symptoms daily for at least two or three cycles, noting the first day of
menstruation, rash appearance, swelling, breathing symptoms, medicines, hormonal treatment and photographs
of visible reactions. A consistent monthly pattern is often more informative than a single laboratory result.

2. Review of hormonal exposure

The clinician will review contraceptive pills, hormonal coils, injections, implants, fertility medicines,
progesterone pessaries, hormone replacement therapy and previous pregnancies. It is important not to stop
a prescribed hormonal medicine without medical advice.

3. Allergy and skin testing

Intradermal or skin-prick testing with progesterone is sometimes used in specialist settings, but protocols
are not standardised. The test solution and its vehicle may irritate the skin, false-positive reactions are
possible, and a negative result cannot confidently rule out the diagnosis.

4. Supervised drug or hormone challenge

A carefully supervised challenge may occasionally help clarify whether a particular progestogen is tolerated.
This can provoke a significant reaction and should only be considered by an experienced specialist in an
appropriately equipped clinical setting.

5. Excluding other conditions

Other causes of recurrent rash or swelling may need to be considered, including chronic spontaneous
urticaria, contact dermatitis, drug allergy, urticarial vasculitis, mast-cell disorders, hereditary
angioedema and other cyclical hormonal conditions.

How is autoimmune progesterone dermatitis treated?

Treatment depends on the severity of symptoms, whether the trigger is endogenous or medication-related,
the need for contraception, plans for pregnancy and any requirement for progesterone during fertility
treatment. Management should be individualised and may involve an allergist, dermatologist, gynaecologist
and fertility specialist.

Symptom control

Non-sedating antihistamines may help urticaria and itching. Topical corticosteroids may be considered for
limited eczema-like inflammation, while short courses of systemic corticosteroids may occasionally be
required for significant flares. These measures may reduce symptoms but do not necessarily prevent the
underlying cyclical reaction.

Ovulation suppression

For patients reacting to their own progesterone, treatment may aim to suppress ovulation and reduce
progesterone fluctuations. Continuous combined hormonal contraception is one option, but it is not suitable
for everyone and may worsen symptoms in patients who react to the progestogen component. Specialist
supervision is essential.

Biological treatment

Omalizumab has been reported in selected patients, particularly where urticaria, angioedema or anaphylaxis
is prominent. Evidence remains limited because the condition is rare, so treatment decisions must be made
on an individual basis.

Progesterone desensitisation

Desensitisation may be considered when progesterone is medically necessary, particularly during in vitro
fertilisation. Protocols have used oral, intramuscular or intravaginal routes. Desensitisation is a high-risk
specialist procedure and continued regular exposure is usually required to maintain tolerance.

Other hormone-suppressing treatments or surgery

Gonadotrophin-releasing hormone medicines and other hormone-modulating treatments have been described in
severe cases. Surgery to remove the ovaries is irreversible and is reserved for exceptionally severe,
treatment-resistant disease when future fertility is not desired.

Pregnancy, IVF and progesterone hypersensitivity

Pregnancy does not affect every patient in the same way. Symptoms may improve, remain unchanged or worsen.
Reactions can also appear for the first time during fertility treatment or after pregnancy. Anyone with
suspected progesterone hypersensitivity who is planning pregnancy or IVF should seek specialist advice
before starting hormonal treatment.

Where progesterone support is essential, an allergy specialist and fertility team may be able to identify
a tolerated preparation or arrange desensitisation. Previous tolerance of pregnancy or progesterone does
not guarantee that future exposure will be reaction-free.

When should you see an allergy specialist?

Consider a specialist assessment if you experience recurrent hives, eczema, swelling or unexplained
allergic reactions that repeatedly occur before your period, or if symptoms began after hormonal
contraception, fertility medication or another progestogen-containing treatment.

Frequently asked questions

Is autoimmune progesterone dermatitis a true allergy?

It is a hypersensitivity disorder. Some patients appear to have an immediate, potentially IgE-mediated
reaction, while others may have delayed immune mechanisms. The exact biology is not fully understood.

Can progesterone allergy cause anaphylaxis?

Yes, although it is rare. Progesterone-induced anaphylaxis has been reported after natural hormonal rises
and after progesterone medicines, including fertility treatment.

Can a progesterone skin test confirm the diagnosis?

A positive test can support the diagnosis, but it cannot confirm the condition on its own. False-positive
and false-negative results occur, and test methods vary between centres.

Can symptoms occur without previous use of hormonal contraception?

Yes. Some patients react to progesterone produced naturally after ovulation and have never knowingly used
an external progestogen.

Should I stop my contraceptive pill or fertility medication?

Do not stop prescribed hormonal treatment without speaking to the clinician responsible for your care.
Sudden changes may affect contraception, fertility treatment or other medical needs.

Clinical summary

Autoimmune progesterone dermatitis or progestogen hypersensitivity should be considered when
allergic or inflammatory symptoms recur in a predictable relationship with the menstrual cycle or
hormonal treatment. Urticaria and itching are common, but presentations range from eczema and
mucosal lesions to angioedema and anaphylaxis. Diagnosis is primarily clinical because current testing is
imperfect. Treatment may include symptom control, ovulation suppression, biological therapy or specialist
desensitisation.

Medical disclaimer: This article is for general information and does not replace
individual medical advice. Seek urgent medical help for breathing difficulty, throat swelling, collapse
or suspected anaphylaxis.

References

1. Bornsztein NT, Grabarz A, Rapozero AL, et al. Autoimmune progesterone dermatitis: diagnostic relevance
   and epidemiological analysis of 13 cases. Rev Bras Ginecol Obstet. 2026;48:e-rbgo30.
2. Bumbăcea RS, Băloiu DA, Vintilă MR, et al. When Hormones Attack: A Literature Review of
   Progesterone-Induced Anaphylaxis. Current Allergy and Asthma Reports. 2026;26(1):24.
3. Mittal S, Aghazadeh Mohandesi N, Divekar R, et al. Cyclical Rash Unveiled – Progestogen
   Hypersensitivity. Mayo Clinic Proceedings. 2026.
4. Bui VK, Cao TT, Nguyen HN. Anaphylaxis due to progesterone hypersensitivity: a rare cause of recurrent
   anaphylaxis. Asia Pacific Allergy. 2026;16(2):138–140.
5. AlSulami M, Alharbi JK, Alzahrani A, et al. Autoimmune Progesterone Dermatitis: A Case Report and Review
   of Literature. Cureus. 2026;18(4):e106760.
6. Chiarella SE, Buchheit KM, Foer D. Progestogen hypersensitivity.
   J Allergy Clin Immunol Pract. 2023;11(12):3606–3613.e2.